advisory boards

Market Access

The latest Board moves reflect a focus on experience in commercialisation, corporate governance, and therapeutic development.

R&D

Boardrooms and advisory panels across biotech, pharma, digital health, and life sciences suppliers saw a wave of high‑profile additions in April.

R&D

Board‑level appointments this month were thick and fast, with six Boards adding new faces as Chairperson.

R&D

Boardrooms and advisory panels across pharma, biotech, medtech, and digital health were busy last month.

R&D

January was a relatively quiet month for Board news, but there were some notable moves here and there.

R&D

As 2025 came to a close, we also saw a modest number of Board appointments, on both advisory and governance Boards.